- Home
- MLAB vs CLDT Comparison
MLAB vs CLDT Comparison
Compare MLAB & CLDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLAB
- CLDT
- Stock Information
- Founded
- MLAB 1982
- CLDT 2009
- Country
- MLAB United States
- CLDT United States
- Employees
- MLAB N/A
- CLDT N/A
- Industry
- MLAB Industrial Machinery/Components
- CLDT Real Estate Investment Trusts
- Sector
- MLAB Industrials
- CLDT Real Estate
- Exchange
- MLAB Nasdaq
- CLDT Nasdaq
- Market Cap
- MLAB 341.1M
- CLDT 374.7M
- IPO Year
- MLAB N/A
- CLDT 2010
- Fundamental
- Price
- MLAB $65.15
- CLDT $6.94
- Analyst Decision
- MLAB Buy
- CLDT Strong Buy
- Analyst Count
- MLAB 2
- CLDT 2
- Target Price
- MLAB $113.50
- CLDT $10.75
- AVG Volume (30 Days)
- MLAB 126.2K
- CLDT 271.2K
- Earning Date
- MLAB 11-06-2025
- CLDT 11-06-2025
- Dividend Yield
- MLAB 0.99%
- CLDT 5.20%
- EPS Growth
- MLAB N/A
- CLDT N/A
- EPS
- MLAB N/A
- CLDT 0.03
- Revenue
- MLAB $242,351,000.00
- CLDT $310,140,000.00
- Revenue This Year
- MLAB $5.38
- CLDT N/A
- Revenue Next Year
- MLAB $5.25
- CLDT $0.58
- P/E Ratio
- MLAB N/A
- CLDT $252.00
- Revenue Growth
- MLAB 8.33
- CLDT N/A
- 52 Week Low
- MLAB $55.45
- CLDT $5.83
- 52 Week High
- MLAB $155.12
- CLDT $10.00
- Technical
- Relative Strength Index (RSI)
- MLAB 47.20
- CLDT 37.46
- Support Level
- MLAB $58.83
- CLDT $7.07
- Resistance Level
- MLAB $67.91
- CLDT $7.25
- Average True Range (ATR)
- MLAB 3.73
- CLDT 0.16
- MACD
- MLAB 0.55
- CLDT -0.07
- Stochastic Oscillator
- MLAB 64.16
- CLDT 6.84
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest
Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.